BackRegenxbio Overview

Regenxbio Current Assets

Track Regenxbio's current assets ($190M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$186.52M
40.46% YoYΔ $-126.72M vs prior year quarter

Peer average

Loading

Regenxbio Current Assets History

Loading

Regenxbio vs. peers: Current Assets Comparison

Loading

Regenxbio Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Regenxbio (RGNX) FAQ

As of the most recent data (March 2026), RGNX shows a current assets of $190M. That compares with $310M in the prior-year period — down 40.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RGNX's current assets is now $190M (was $310M) — a 40.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Regenxbio is outperforming or lagging.

Tracking RGNX's current assets over time shows whether Regenxbio is scaling, shrinking, or reshaping that part of the business. The current reading is $190M That compares with $310M in the prior-year period — down 40.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Regenxbio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $190M) with ownership activity and broader fundamentals.

Regenxbio's current assets is $190M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.